Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This pilot, randomized phase I/II trial studies how well inositol works in preventing
colorectal cancer in patients with abnormal cells (dysplasia) associated with inflammation of
the colon (colitis). Patients with colitis-associated dysplasia may have an increased risk of
developing colorectal cancer. Inositol is a vitamin-like substance that may stop the growth
of tumor cells by blocking some of the enzymes needed for cell growth.